cbdMD (YCBD) Non-Current Assets (2016 - 2025)
cbdMD (YCBD) reported Non-Current Assets of $3.6 million for Q4 2025, down 30.21% on a YoY basis from $5.2 million in Q4 2024, and down 6.51% sequentially from $3.9 million in Q3 2025.
cbdMD (YCBD) Non-Current Assets (2016 - 2025) Analysis & Trends
cbdMD (YCBD) has 10 years of Non-Current Assets data on file, last reported at $3.6 million in Q4 2025.
- For the quarter ending Q4 2025, Non-Current Assets fell 30.21% year-over-year to $3.6 million; the trailing twelve-month figure through Dec 2025 stood at $16.5 million (down 28.35% YoY), and the FY2025 full-year result was $3.9 million, down 7.72% from the prior year.
- Non-Current Assets slipped to $3.6 million in Q4 2025, from $3.9 million in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $88.4 million in Q3 2021 to a low of $3.6 million in Q4 2025.
- A 5-year average of $29.3 million and a median of $15.5 million in 2023 frame the typical range for Non-Current Assets.
- Across the five-year window, Non-Current Assets advanced 1.44% in 2021 and plunged 71.96% in 2022, its largest moves.
- Tracing YCBD's Non-Current Assets over 5 years: stood at $69.6 million in 2021, then slumped by 65.26% to $24.2 million in 2022, then tumbled by 68.06% to $7.7 million in 2023, then tumbled by 32.95% to $5.2 million in 2024, then slumped by 30.21% to $3.6 million in 2025.
- Business Quant data shows YCBD's Non-Current Assets at $3.6 million in Q4 2025, $3.9 million in Q3 2025, and $4.3 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 36.78 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 26.33 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 8.68 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 79.20 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 3.84 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 15.70 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 25.92 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2.47 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 9.64 Bn |
| 10 | cbdMD | 438,678.80 | -2.95 Mn | 3.00 Mn | 3.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.62 Mn |
| Sep 30, 2025 | 3.87 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 4.75 Mn |
| Dec 31, 2024 | 5.18 Mn |
| Sep 30, 2024 | 4.19 Mn |
| Jun 30, 2024 | 6.55 Mn |
| Mar 31, 2024 | 7.14 Mn |
| Dec 31, 2023 | 7.73 Mn |
| Sep 30, 2023 | 8.13 Mn |
| Jun 30, 2023 | 22.88 Mn |
| Mar 31, 2023 | 23.54 Mn |
| Dec 31, 2022 | 24.20 Mn |
| Sep 30, 2022 | 24.78 Mn |
| Jun 30, 2022 | 37.28 Mn |
| Mar 31, 2022 | 68.66 Mn |
| Dec 31, 2021 | 69.65 Mn |
| Sep 30, 2021 | 88.38 Mn |
| Jun 30, 2021 | 85.54 Mn |
| Mar 31, 2021 | 86.31 Mn |